Fed. Circ. Nixes Teva Bid To Halt Generic Seasonique

Law360, New York (November 10, 2011, 4:59 PM EST) -- The U.S. Court of Appeals for the Federal Circuit on Thursday shot down an appeal by a unit of Teva Pharmaceutical Industries Ltd. that sought to block a subsidiary of Watson Pharmaceuticals Inc. from selling a generic version of birth control drug Seasonique.

The Federal Circuit entered its judgment without comment.

The move is the latest blow to Teva, which claims Watson's Seasonique copycat infringes U.S. Patent Number 7,320,969, which was issued to Teva's old Duramed division in 2008.

Teva had sought to overturn a lower...
To view the full article, register now.